Engineered progenitor cells and methods of use

Michele De Palma, Ali Ghasemi
2023
Brevet

Résumé

Disclosed herein are engineered progenitor cells and methods of using the same. Also disclosed herein are engineered cells differentiated from engineered progenitor cells of the present disclosure. Also disclosed herein are methods of treating a condition in a subject by administering an engineered progenitor cell or an engineered cell differentiated from an engineered progenitor cell of the present disclosure.

Source officielle

https://infoscience.epfl.ch/record/307210?ln=fr

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Engineered progenitor cells and methods of use

Molecular Regulation of Muscle Stem Cell Fate during Skeletal Muscle Regeneration and Aging

A single-cell-based identification and characterisation of Aregs, an inhibitory subpopulation of adipose stem and precursor cells

Molecular Regulation of Muscle Stem Cell Fate during Skeletal Muscle Regeneration and Aging

A single-cell-based identification and characterisation of Aregs, an inhibitory subpopulation of adipose stem and precursor cells